Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

EPOR Antikörper

Dieses Maus Monoklonal-Antikörper erkennt spezifisch EPOR in FACS und cELISA. Er zeigt eine Reaktivität gegenüber Human und wurde in 2+ Publikationen erwähnt.
Produktnummer ABIN1720915

Kurzübersicht für EPOR Antikörper (ABIN1720915)

Target

EPOR (Erythropoietin Receptor (EPOR))

Reaktivität

  • 120
  • 49
  • 47
  • 8
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Wirt

  • 107
  • 26
  • 4
  • 1
Maus

Klonalität

  • 113
  • 24
  • 1
Monoklonal

Konjugat

  • 81
  • 13
  • 8
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser EPOR Antikörper ist unkonjugiert

Applikation

  • 108
  • 43
  • 42
  • 34
  • 27
  • 25
  • 20
  • 14
  • 14
  • 5
  • 5
  • 5
  • 4
  • 2
  • 2
  • 1
Flow Cytometry (FACS), Cell-ELISA (cELISA)

Klon

VP-2E8
  • Spezifität

    Anti-human Epo-R

    Produktmerkmale

    Selection: Based on recognition of the complete native protein expressed on transfected mammalian cells

    Aufreinigung

    Protein G

    Immunogen

    genetic immunisation with cDNA encoding the ECD of human Epo-R

    Isotyp

    IgG1
  • Applikationshinweise

    Flow cytometry: 1.2 µg/10^6 cells
    ELISA: 1:200 - 1:400
    CELISA: 1:200 - 1:400
    For each application a titration should be performed to determine the optimal concentration.

    Kommentare

    Synonyms: Erythropoietin receptor

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Buffer

    PBS, pH 7.2

    Handhabung

    Avoid repeated freezing and thawing.

    Lagerung

    4 °C

    Informationen zur Lagerung

    short term: 2 °C - 8 °C, long term: -20 °C
  • Maxwell, Melendez-Rodríguez, Matchett, Aragones, Ben-Califa, Jaekel, Hengst, Lindner, Bernardini, Brockmeier, Fandrey, Grunert, Oster, Mittelman, El-Tanani, Thiersch, Schneider Gasser, Gassmann et al.: "Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementation. ..." in: British journal of haematology, Vol. 168, Issue 3, pp. 429-42, (2015) (PubMed).

    Hedley, Allan, Xenocostas: "The role of erythropoietin and erythropoiesis-stimulating agents in tumor progression." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 17, Issue 20, pp. 6373-80, (2011) (PubMed).

  • Target

    EPOR (Erythropoietin Receptor (EPOR))

    Andere Bezeichnung

    EPOR

    Hintergrund

    Erythropoietin receptor (Epo-R) belongs to the cytokine receptor family and is a 507 amino acid type I transmembrane protein. EpoR pre-exists as dimers which changes the homodimerized state after binding of its 34 kDa ligand erythropoietin (Epo). Erythropoietin is the primary regulator of erythropoiesis, and promotes the survival, proliferation, and differentiation of erythroid progenitor cells. Both, Epo and Epo-R are essential for the production of red blood cells due to Epo exerts its function through the Epo receptor. The Epo-R is also expressed in many organs outside the bone marrow, suggesting that Epo is a pleiotropic anti-apoptotic factor. Signaling pathways have been shown to influence numerous cellular functions in normal and tumor cells, including proliferation, apoptosis, and drug resistance.

    UniProt

    P19235

    Pathways

    JAK-STAT Signalweg
Sie sind hier:
Chat with us!